Time: October 10, 2016 from 12pm to 1pm
Location: Phone Call - Eastern Time Zone
Website or Map: http://www.readytalk.com/acco…
Phone: 1.866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: Oct 10, 2016
Monday, October 10th at 12pm EDT
Sarepta Therapeutics and Summit recently announced a license and collaboration agreement, which grants Sarepta the right to commercialize Summit's utrophin modulators in Europe should they receive approval. This includes ezutromid, which is currently in the Phase 2 PhaseOut DMD trial. PPMD will be hosting a community update call with Sarepta and Summit on Monday, October 10 at 12:00pm EDT to answer any of your questions.
To join the call:
Audio Dial-In Information:
Please submit questions in advance to email@example.com (subject line: Sarepta/Summit Call).